Skip to content

New study looks at impact of AIDS on South Africa

Advocacy groups demand equal HIV treatment access for injecting drug users

Limb fat gains lower when switching from AZT to abacavir or tenofovir, compared with d4T

HAART reduces liver damage in HIV / hepatitis C co-infected patients

Primary drug resistance has limited effect on disease progression and response to treatment

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Clostridium difficile most common cause of bacterial diarrhoea in HIV-positive patients

Neurological side-effects of efavirenz mild and transient, study claims

HIV-positive injecting drug users who are infected with HTLV-II less are less likely to progress to AIDS